Ophtec Unfazed By FDA Panel Limitations On Phakic IOL Patient Group
This article was originally published in The Gray Sheet
Executive Summary
Ophtec expects FDA to approve its Artisan phakic intraocular lens in the next six months with less restrictive labeling than recommended by the Ophthalmic Devices Panel Feb. 5
You may also be interested in...
Staar Tackles Compliance Issues; AMO Sets Sights On Overseas Lens Market
Staar Surgical will create a dedicated compliance office as part of an operational restructuring to boost its regulatory standing in the wake of two warning letters issued by FDA since December
Staar Tackles Compliance Issues; AMO Sets Sights On Overseas Lens Market
Staar Surgical will create a dedicated compliance office as part of an operational restructuring to boost its regulatory standing in the wake of two warning letters issued by FDA since December
AMO Adds Glaucoma Device, Fills Cataract Line With $450 Mil. Pfizer Eye Unit
Advanced Medical Optics' purchase of Pfizer's surgical ophthalmology business bolsters its cataract surgery portfolio by adding viscoelastics and expanded intraocular lens (IOL) offerings